Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Viking Therapeutics Inc
VKTX
Healthcare
Biotechnology
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company’s lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non...
-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:VKTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(544)
•••
Galaxym31
X
Post by
Galaxym31
on May 05, 2025 6:06pm
Pop into the 40's soon .
IMO
(544)
•••
Galaxym31
X
Post by
Galaxym31
on Apr 29, 2025 10:51am
Could explode up at any moment eh.
So cheap 852 million in the bank.
(163)
•••
TrevorAbes
X
Post by
TrevorAbes
on Feb 28, 2024 11:37am
Viking's new weight-loss drug shows early potential
https://stockhouse.com/news/the-market-online-news/2024/02/28/viking-therapeutics-new-weight-loss-drug-shows-early-potential
(544)
•••
Galaxym31
X
Post by
Galaxym31
on Dec 05, 2023 4:39pm
Easy market cap of 5 billion US
yes
(544)
•••
Galaxym31
X
Post by
Galaxym31
on Dec 04, 2023 11:53am
Take over target now eh .
.
(544)
•••
Galaxym31
X
Post by
Galaxym31
on Jun 27, 2023 11:42am
Blood bath nothing from the company , not a good look .
.
(544)
•••
Galaxym31
X
Post by
Galaxym31
on Apr 21, 2023 12:47pm
Maybe Merck is interested .
.
(544)
•••
Galaxym31
X
Post by
Galaxym31
on Apr 12, 2023 12:50pm
Wonder if a take out offer is coming .
$$$$
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 19, 2022 1:12pm
VKTX 6.79 7.03 7.35 possible key lines
Fib......618 is 7.67
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 19, 2022 1:10pm
VKTX....... n.h.o.d $7.04
Vols are great
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 19, 2022 12:56pm
VKTX .....watch for a breakout over $7
Looks very strong !!!!
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Environmental technology company enters a new strategic phase focused on scale and profitability